INNO-206 in Patients With Small Cell Lung Cancer (SCLC)

Phase I Study of SPH1188-11 in NSCLC

NCT03231475 ·Status: WITHDRAWN ·Phase: PHASE1

Crizotinib Plus Pembrolizumab In Alk-Positive Advanced Non Small Cell Lung Cancer Patients

NCT02511184 ·Status: TERMINATED ·Phase: PHASE1

Pegylated Irinotecan NKTR 102 in Treating Patients With Relapsed Small Cell Lung Cancer

NCT01876446 ·Status: COMPLETED ·Phase: PHASE2

MK2206 and Erlotinib Hydrochloride in Treating Patients With Advanced Non-Small Cell Lung Cancer Who Have Progressed After Previous Response to Erlotinib Hydrochloride Therapy

NCT01294306 ·Status: COMPLETED ·Phase: PHASE2

-02341066 and PF-00299804 for Advanced Non-Small Cell Lung Cancer

NCT01441128 ·Status: TERMINATED ·Phase: PHASE1

A Study of QL1706 Combined With Chemotherapy in Advanced Non-small Cell Lung Cancer

NCT05329025 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

Ipilimumab and Nivolumab in Recurrent Extensive Stage Small Cell Lung Cancer After Receiving Platinum-based Chemotherapy

NCT03670056 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

Pioglitazone Hydrochloride in Treating Patients With Stage IA-IIIA Non-small Cell Lung Cancer

NCT01342770 ·Status: TERMINATED ·Phase: PHASE2

Irinotecan Liposome(II) Combined With Ivonescimab as Second-line Treatment for Small Cell Lung Cancer : A Prospective, Single-arm, Multicenter Clinical Study

NCT06820762 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2

Feasibility and Safety Study of Nivolumab With Irinotecan for Small Cell Lung Cancer

NCT04173325 ·Status: TERMINATED ·Phase: PHASE1

Testing the Use of Targeted Treatment (AMG 510) for KRAS G12C Mutated Advanced Non-squamous Non-small Cell Lung Cancer (A Lung-MAP Treatment Trial)

NCT04625647 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

Oxaliplatin and Docetaxel as First-line Therapy for Advanced Non-small Cell Lung Cancer

NCT00145418 ·Status: TERMINATED ·Phase: PHASE2

Platform Trial of Novel Regimens Versus Standard of Care (SoC) in Participants With Non-small Cell Lung Cancer (NSCLC) - Sub-study 2

NCT06790303 ·Status: TERMINATED ·Phase: PHASE2

Study of Irinotecan Liposome Injection as Second-line Regimen in Patients With Small Cell Lung Cancer (SCLC)

NCT04727853 ·Status: COMPLETED ·Phase: PHASE2

A Phase II Study of QL1706 With Anti-angiogenesis Therapy and Chemotherapy in Extensive-stage Small Cell Lung Cancer.

NCT07083375 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2

An Umbrella Study of Recurrent, Extensive Stage Small Cell Lung Cancer Based on Molecular Typing

NCT07141771 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1/PHASE2

Picoplatin as Second-Line Therapy for Patients With Small Cell Lung Cancer

NCT00116610 ·Status: COMPLETED ·Phase: PHASE2

Chemotherapy in Treating Patients With Lung Cancer

NCT01067794 ·Status: COMPLETED

RO5126766 for Patients With Advanced KRAS-Mutant Lung Cancer

NCT03681483 ·Status: COMPLETED ·Phase: PHASE1

A Study to Assess the Safety and Preliminary Efficacy of PT-523 in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)

NCT00112060 ·Status: WITHDRAWN ·Phase: PHASE1/PHASE2

Risk-adapted, Proteomic-guided Systemic Therapy for Previously Untreated Advanced Non-small Cell Lung Cancer

NCT07250477 ·Status: RECRUITING ·Phase: PHASE2

Anlotinib Plus Durvalumab-Platinum-Etoposide in First-line Treatment Extensive Small-cell Lung Cancer

NCT04660097 ·Status: COMPLETED ·Phase: PHASE2

A Study of Nivolumab +/- Nab-paclitaxel in Non-small Cell Lung Cancer

NCT02967133 ·Status: TERMINATED ·Phase: PHASE2

PR104 in Treating Patients With Previously Untreated or Relapsed Small Cell Lung Cancer

NCT00544674 ·Status: TERMINATED ·Phase: PHASE2

Pembrolizumab vs Topotecan in Patients With Small Cell Lung Cancer

NCT02963090 ·Status: TERMINATED ·Phase: PHASE2